A. Graham

Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-1997, as assessed by routine and centralized testing.

D. Livermore, D. James, A. Johnson, 2000, The Journal of antimicrobial chemotherapy.

Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar.

E. Threlfall, L. Ward, J. Skinner, 2000, Microbial drug resistance.

A comparison of antimicrobial susceptibilities in nontyphoidal salmonellas from humans and food animals in England and Wales in 2000.

C. Cassar, R. Davies, E. Threlfall, 2003, Microbial drug resistance.

Rechallenge of lamotrigine after development of rash

J. Houser, A. Graham, 2018, The mental health clinician.

Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996.

T. Cheasty, E. Threlfall, B. Rowe, 1997, Journal of clinical pathology.

Resistance to ceftriaxone and cefotaxime in non-typhoidal Salmonella enterica in England and Wales, 1998-99.

E. Threlfall, L. Ward, H. Smith, 2000, The Journal of antimicrobial chemotherapy.

Antibiotic resistance in Escherichia coli isolated from blood and cerebrospinal fluid: a 6-year study of isolates from patients in England and Wales.

T. Cheasty, E. Threlfall, B. Rowe, 1997, International journal of antimicrobial agents.

High-level resistance to ciprofloxacin in Escherichia coli

T. Cheasty, E. Threlfall, B. Rowe, 1997, The Lancet.